Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Langdon

Showing results (171-180 of 180) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 180 results.
The Journal of Pathology|December 21, 2011
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancerCharlotte K Y Ng, Susanna L Cooke, Kevin Howe, et al.
British Journal of Cancer|April 1, 2016
Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer modelsCarlos Martínez-Pérez, Carol Ward, Arran K Turnbull, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Estrogen regulation of transforming growth factor-alpha in ovarian cancerB J Simpson, S P Langdon, G J Rabiasz, et al.
British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.
Oncotarget|May 6, 2017
Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cellsJames Meehan, Carol Ward, Arran Turnbull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patientsJohn F Smyth, Charlie Gourley, Graeme Walker, et al.
Oncotarget|August 11, 2015
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer modelsCarol Ward, James Meehan, Peter Mullen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumErik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 18

Showing results (171-180 of 180) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 180 results.
The Journal of Pathology|December 21, 2011
The role of tandem duplicator phenotype in tumour evolution in high-grade serous ovarian cancerCharlotte K Y Ng, Susanna L Cooke, Kevin Howe, et al.
British Journal of Cancer|April 1, 2016
Antitumour activity of the novel flavonoid Oncamex in preclinical breast cancer modelsCarlos Martínez-Pérez, Carol Ward, Arran K Turnbull, et al.
British Journal of Cancer|July 15, 2010
A gene on the HER2 amplicon, C35, is an oncogene in breast cancer whose actions are prevented by inhibition of SykE Katz, S Dubois-Marshall, A H Sims, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 30, 1998
Estrogen regulation of transforming growth factor-alpha in ovarian cancerB J Simpson, S P Langdon, G J Rabiasz, et al.
British Journal of Cancer|February 1, 1996
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancerJ M Bartlett, S P Langdon, B J Simpson, et al.
Oncotarget|May 6, 2017
Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cellsJames Meehan, Carol Ward, Arran Turnbull, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor-positive patientsJohn F Smyth, Charlie Gourley, Graeme Walker, et al.
Oncotarget|August 11, 2015
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer modelsCarol Ward, James Meehan, Peter Mullen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|October 28, 2014
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortiumErik O Pettersen, Peter Ebbesen, Roben G Gieling, et al.
Breast Cancer Research : BCR|November 30, 2013
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerSuzanne A Eccles, Eric O Aboagye, Simak Ali, et al.
Pageof 18